Burnham Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$6.12M Buy
73,370
+37,785
+106% +$3.35M 1.71% 12
2016
Q1
$3.27M Sell
35,585
-900
-2% -$81.2K 1.04% 26
2015
Q4
$3.69M Sell
36,485
-1,560
-4% -$162K 1.01% 29
2015
Q3
$3.74M Buy
38,045
+850
+2% +$94.4K 0.99% 28
2015
Q2
$4.36M Buy
37,195
+6,575
+21% +$718K 1.01% 26
2015
Q1
$3M Buy
30,620
+5,138
+20% +$522K 0.69% 40
2014
Q4
$2.4M Buy
25,482
+11,870
+87% +$1.23M 0.55% 50
2014
Q3
$1.45M Buy
13,612
+4,312
+46% +$422K 0.32% 84
2014
Q2
$771K Buy
9,300
+6,200
+200% +$483K 0.17% 142
2014
Q1
$220K Buy
+3,100
New +$243K 0.05% 239

Other funds holding GILD

Burnham Asset Management's GILD Position: Q2 2016 in Review

Burnham Asset Management increased its Gilead Sciences (GILD) stake by 106% in Q2 2016, buying an estimated $3.35M and bringing the position to 73,370 shares worth $6.12M. The position accounts for 1.71% of the portfolio, ranked #12.

Burnham Asset Management first reported a position in GILD in Q1 2014 and has held it in 10 quarters since. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • Burnham Asset Management held 73,370 shares of Gilead Sciences worth $6.12M as of Q2 2016.
  • Burnham Asset Management bought 37,785 Gilead Sciences shares in Q2 2016, an estimated $3.35M.
  • Gilead Sciences made up 1.71% of Burnham Asset Management's portfolio in Q2 2016, its #12 holding.
  • Burnham Asset Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 10 quarters since.
  • 1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.